Functional Type 1 diabetes cure research enjoys breakthrough as long-term VX-880 trials feature patients attaining insulin independence

[Redaktion]

Vertex Pharmaceuticals has issued a press release that could leave millions of people suffering from type 1 diabetes (T1D) with cautious optimism in regard to a cure. By using VX-880 stem-cell therapy in a long-term trial, three patients who had coped with diabetes for decades had "achieved insulin independence". The current study will last until 2028.

https://www.notebookcheck.net/Functional-Type-1-diabetes-cure-research-enjoys-breakthrough-as-long-term-VX-880-trials-feature-patients-attaining-insulin-independence.759152.0.html

[Anonymousgg]

The zombies are doing the conga line. They want to participate in YOUR drug trial.